• Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

  • Dec 6 2023
  • Length: 29 mins
  • Podcast

Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

  • Summary

  • Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment in endometrial carcinoma. Single-agent immunotherapies (pembrolizumab and dostarlimab), and now immunotherapy and antiangiogenic therapy combinations (pembrolizumab and lenvatinib), are transforming treatment pathways, with OS benefits in the second-line now achievable. They offer tips for managing the toxicity of these novel therapeutic options and set the stage for 2023, a year which promises a paradigm shift in the use of systemic treatments in this once underserved malignancy.

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.